Table 1 Antibiotic susceptibility profile of clinical isolates and S.aureus NCIM 2127 (zone diameters achieved were compared with the CLSI standards)
From: Invitro synergistic activity of lactic acid bacteria against multi-drug resistant staphylococci
Zone diameters in mm | ||||||||
|---|---|---|---|---|---|---|---|---|
SAMPLES | AK | CIP | GEN | CAZ | CPM | CX | CTX | CTR |
Staph A | 12 (R) | 11 (R) | 7 (R) | 17 (I) | 15 (I) | 17 (R) | 24 (S) | 16 (I) |
Staph B | 10 (R) | 17 (I) | 9 (R) | 13 (R) | 17 (I) | 19 (R) | 24 (S) | 17 (I) |
Staph C | 11 (R) | 10 (R) | 8 (R) | 17 (I) | 17 (I) | 19 (R) | 24 (S) | 16 (I) |
Staph D | 11 (R) | 10 (R) | 8 (R) | 17 (I) | 16 (I) | 15 (R) | 22 (I) | 16 (I) |
Staph E | 10 (R) | 17 (I) | 10 (R) | 16 (I) | 17 (I) | 15 (R) | 21 (I) | 14 (I) |
Staph F | 8 (R) | 9 (R) | 4 (R) | 11 (R) | 11 (R) | 10 (R) | 11 (R) | 11 (R) |
Staph G | 10 (R) | 11 (R) | 11 (R) | 14 (R) | 12 (R) | 14 (R) | 12 (R) | 11 (R) |
Staph H | 11 (R) | 13 (R) | 11 (R) | 13 (R) | 12 (R) | 13 (R) | 13 (R) | 8 (R) |
Staph I | 11 (R) | 11 (R) | 8 (R) | 13 (R) | 16 (I) | 19 (R) | 17 (I) | 16 (I) |
S.aureus NCIM 2127 | 22 (S) | 21 (S) | 22 (S) | 24 (S) | 21 (S) | 23 (S) | 24 (S) | 24 (S) |